Y-Biologics (XKRX:338840) Receivables Turnover : 0.94 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Y-Biologics's Revenue for the three months ended in Jun. 2024 was ₩232 Mil. Y-Biologics's average Accounts Receivable for the three months ended in Jun. 2024 was ₩246 Mil. Hence, Y-Biologics's Receivables Turnover for the three months ended in Jun. 2024 was 0.94.

Y-Biologics Receivables Turnover Historical Data

The historical data trend for Y-Biologics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Receivables Turnover Chart

Y-Biologics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

72.15

53.93

9.04

5.48

5.51

Y-Biologics Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Receivables Turnover	Get a 7-Day Free Trial					2.48	14.83	1.72	2.59	0.94

Competitive Comparison of Y-Biologics's Receivables Turnover

For the Biotechnology subindustry, Y-Biologics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Y-Biologics's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Y-Biologics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Y-Biologics's Receivables Turnover falls into.

Y-Biologics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Y-Biologics's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	3479.081	/ (	(689.881	+	573.375)	/	2 )
=	3479.081	/	631.628
=	5.51

Y-Biologics's Receivables Turnover for the quarter that ended in Jun. 2024 is calculated as

	Receivables Turnover (Q: Jun. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2024 )	/ (	(Accounts Receivable (Q: Mar. 2024 )	+	Accounts Receivable (Q: Jun. 2024 ))	/	count )
=	232.007	/ (	(310.123	+	181.261)	/	2 )
=	232.007	/	245.692
=	0.94

Y-Biologics (XKRX:338840) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Y-Biologics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR

Website

https://www.ybiologics.com

Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics Headlines

No Headlines